As of close of business last night, Zentalis Pharmaceuticals Inc.’s stock clocked out at $22.49, down -3.93% from its previous closing price of $23.41. In other words, the price has decreased by -$0.92 from its previous closing price. On the day, 510314 shares were traded. ZNTL stock price reached its highest trading level at $23.52 during the session, while it also had its lowest trading level at $22.45.
To gain a deeper understanding of ZNTL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.90 and its Current Ratio is at 10.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 11 when Skvarka Jan sold 5,000 shares for $25.05 per share. The transaction valued at 125,238 led to the insider holds 47,970 shares of the business.
Matrix Capital Management Comp bought 4,760,000 shares of ZNTL for $107,861,600 on Jun 20. The 10% Owner now owns 13,959,973 shares after completing the transaction at $22.66 per share. On May 31, another insider, Gallagher Cam, who serves as the President of the company, sold 27,768 shares for $26.27 each. As a result, the insider received 729,506 and left with 463,502 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 1.59B and an Enterprise Value of 1.08B.
Stock Price History:
Over the past 52 weeks, ZNTL has reached a high of $31.46, while it has fallen to a 52-week low of $15.55. The 50-Day Moving Average of the stock is 25.96, while the 200-Day Moving Average is calculated to be 22.92.
It appears that ZNTL traded 578.04K shares on average per day over the past three months and 729.29k shares per day over the past ten days. A total of 70.61M shares are outstanding, with a floating share count of 68.72M. Insiders hold about 2.80% of the company’s shares, while institutions hold 102.09% stake in the company. Shares short for ZNTL as of Aug 30, 2023 were 12M with a Short Ratio of 12.00M, compared to 13.32M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 17.00% and a Short% of Float of 23.16%.
As of right now, 8 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.94 for the current quarter, with a high estimate of -$0.76 and a low estimate of -$1.24, while EPS last year was -$0.96. The consensus estimate for the next quarter is -$1.07, with high estimates of -$0.79 and low estimates of -$1.43.
Analysts are recommending an EPS of between -$4.04 and -$5.43 for the fiscal current year, implying an average EPS of -$4.82. EPS for the following year is -$4.46, with 9 analysts recommending between -$3.38 and -$6.18.